Skip to content

新闻稿

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Cowen’s Liquid Biopsy Summit
Thursday, September 24, 2020 at 9:30am Pacific Time

The live webcasts can be accessed in the Investor Info section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentations will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram and YouTube.

Investors:
Jacquie Ross, CFA
+1.858.882.2172
ir@illumina.com

Media:
Dr. Karen Birmingham
+44.7500.105665
kbirmingham@illumina.com

Source: Illumina, Inc.

Recent Articles

Illumina–墨尔本大学基因组学中心简介
Illumina–墨尔本大学基因组学中心简介
因美纳NextSeq™550Dx基因测序仪在中国获批用于临床诊断
因美纳NextSeq™550Dx基因测序仪在中国获批用于临床诊断
改变急性骨髓性白血病的诊断和护理
改变急性骨髓性白血病的诊断和护理